Search for: "Abbott v. Abbott" Results 1921 - 1940 of 2,301
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Mar 2012, 7:25 am by Gritsforbreakfast
For some states, that could require major spending on court-appointed lawyers for thousands of convicts.The federal case mentioned is Martinez v. [read post]
12 Apr 2016, 3:59 am by Amy Howe
” In The Economist, Steven Mazie weighs in on last week’s ruling in Evenwel v. [read post]
20 May 2022, 11:01 am by Gus Hurwitz
Alden Abbott and Andrew Mercado remind us that these calls are misplaced. [read post]
14 Sep 2015, 7:41 am by John McFarland
Another recent example is BCCA Appeal Group, Inc. v. [read post]
25 May 2011, 4:59 am by Marie Louise
(Kluwer Patent Blog) USPTO statement at WIPO side event on Medicines Patent Pool (Knowledge Ecology International) US: To implement health reform orphan drug exclusion, HRSA issues first-ever proposed regulation on 340B drug discount program (FDA Law Blog) US: FDA officials hint at provisions of biosimilar guidances (Patent Docs) US: Huffington Post: Data Exclusivity: Getting the balance right (PatentlyBIOtech) US: Report gauges economic impact of Human Genome Project (Patent Docs) US: Chairman… [read post]
21 Oct 2018, 9:30 pm by Mark Nakahara
For example, in 2017 Texas Governor Greg Abbott signed a ban on sanctuary cities. [read post]
4 Apr 2025, 9:41 am by Josh Blackman
 To put it another way, such a reading of § 706 would obviate Abbott Laboratories v. [read post]
22 May 2016, 4:05 pm by INFORRM
On 16 May 2016 Sir David Eady heard a PTR in the case of Bloor v Beresford. [read post]
16 Mar 2011, 3:50 am by Marie Louise
(Kluwer Patent Blog) US: Abraxis Biosciences v Navinta en banc denied – looking back to DBB, forward to Stanford/Roche (IPBiz) US: W D Washington denies preliminary injunction in biotech trademark dispute: Mirina Corp. v Marina Biotech (Seattle Trademark Lawyer) US: Issues to consider when structuring medical device development and license agreements (IP Spotlight) US: Have you benefited from public access to PubMed? [read post]
10 Oct 2008, 11:32 am
:Interpharma Pty Ltd v Commisioner of Patents (GenericsWeb) Gemzar (Gemcitabine) - US: Eli Lilly sues Teva for patent infringement and seek declaratory judgment (The IP Factor) (Law360) Glivec (Imatinib) - India: Supreme Court appoints Dr Chakraborty as technical member on IPAB panel hearing Glivec appeal (Spicy IP) Jeevani (Arogyapacha) - India: Recent developments in the Arogypacha case (Spicy IP) Miralax (Polyethylene glycol) - US: 'Advice of scientist' defense… [read post]